Max Healthcare held an earnings call on November 7, 2024, discussing strong growth in Q2 and H1 FY25, driven by acquisitions and successful integration, with combined revenue of Rs. 130 crore and EBITDA of Rs. 33 crore, marking 40% year-on-year growth.